Hollencrest Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.48M Buy
4,074
+1
+0% +$342 0.1% 120
2026
Q1
$1.43M Hold
4,073
0.05% 131
2025
Q4
$1.33M Buy
4,073
+61
+2% +$19.4K 0.05% 130
2025
Q3
$1.13M Buy
4,012
+40
+1% +$11.6K 0.04% 142
2025
Q2
$1.11M Sell
3,972
-89
-2% -$25.2K 0.05% 133
2025
Q1
$1.27M Sell
4,061
-1
-0% -$295 0.05% 126
2024
Q4
$1.06M Sell
4,062
-80
-2% -$23.7K 0.04% 144
2024
Q3
$1.33M Buy
4,142
+6
+0.1% +$1.96K 0.05% 125
2024
Q2
$1.29M Hold
4,136
0.06% 117
2024
Q1
$1.18M Hold
4,136
0.05% 131
2023
Q4
$1.19M Buy
4,136
+105
+3% +$28.6K 0.11% 112
2023
Q3
$1.08M Hold
4,031
0.12% 104
2023
Q2
$895K Sell
4,031
-29
-0.7% -$6.73K 0.09% 119
2023
Q1
$982K Buy
4,060
+825
+26% +$203K 0.1% 109
2022
Q4
$850K Sell
3,235
-15
-0.5% -$4.02K 0.11% 109
2022
Q3
$733K Buy
3,250
+37
+1% +$8.97K 0.09% 112
2022
Q2
$782K Hold
3,213
0.09% 120
2022
Q1
$777K Hold
3,213
0.07% 146
2021
Q4
$722K Hold
3,213
0.06% 163
2021
Q3
$683K Hold
3,213
0.06% 159
2021
Q2
$783K Hold
3,213
0.07% 142
2021
Q1
$800K Sell
3,213
-161
-5% -$38.4K 0.08% 141
2020
Q4
$775K Buy
3,374
+50
+2% +$11.5K 0.08% 129
2020
Q3
$844K Sell
3,324
-96
-3% -$23.8K 0.1% 114
2020
Q2
$807K Hold
3,420
0.11% 114
2020
Q1
$693K Hold
3,420
0.1% 130
2019
Q4
$824K Hold
3,420
0.09% 134
2019
Q3
$661K Hold
3,420
0.08% 142
2019
Q2
$630K Sell
3,420
-12
-0.3% -$2.15K 0.08% 145
2019
Q1
$652K Sell
3,432
-134
-4% -$25.6K 0.09% 140
2018
Q4
$695K Sell
3,566
-3,421
-49% -$667K 0.1% 128
2018
Q3
$1.39M Buy
6,987
+3,448
+97% +$680K 0.09% 129
2018
Q2
$653K Sell
3,539
-394
-10% -$69.7K 0.09% 136
2018
Q1
$671K Buy
3,933
+5
+0.1% +$918 0.09% 134
2017
Q4
$683K Buy
3,928
+1
+0% +$177 0.09% 137
2017
Q3
$732K Sell
3,927
-999
-20% -$177K 0.1% 131
2017
Q2
$848K Buy
4,926
+1,501
+44% +$244K 0.13% 112
2017
Q1
$562K Buy
+3,425
New +$569K 0.08% 164
2016
Q3
Sell
-3,478
Closed -$529K 372
2016
Q2
$529K Buy
+3,478
New +$541K 0.08% 180
2016
Q1
Sell
-1,731
Closed -$281K 404
2015
Q4
$281K Hold
1,731
0.05% 283
2015
Q3
$239K Sell
1,731
-1,178
-40% -$186K 0.04% 297
2015
Q2
$446K Sell
2,909
-835
-22% -$134K 0.06% 203
2015
Q1
$598K Buy
3,744
+69
+2% +$10.9K 0.08% 170
2014
Q4
$585K Buy
3,675
+727
+25% +$113K 0.08% 179
2014
Q3
$414K Buy
2,948
+48
+2% +$6.27K 0.06% 224
2014
Q2
$344K Sell
2,900
-458
-14% -$53K 0.05% 253
2014
Q1
$414K Buy
3,358
+282
+9% +$34.2K 0.06% 202
2013
Q4
$351K Buy
+3,076
New +$350K 0.06% 212

Other funds holding AMGN

Hollencrest Capital Management's AMGN Position: Q2 2026 in Review

Hollencrest Capital Management increased its Amgen (AMGN) stake by 0.02% in Q2 2026, buying an estimated $342 and bringing the position to 4,074 shares worth $1.48M. The position accounts for 0.1% of the portfolio, ranked #120.

Hollencrest Capital Management first reported a position in AMGN in Q4 2013 and has held it in 48 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Hollencrest Capital Management held 4,074 shares of Amgen worth $1.48M as of Q2 2026.
  • Hollencrest Capital Management bought 1 Amgen share in Q2 2026, an estimated $342.
  • Amgen made up 0.1% of Hollencrest Capital Management's portfolio in Q2 2026, its #120 holding.
  • Hollencrest Capital Management first reported a position in Amgen in Q4 2013 and has held it in 48 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Hollencrest Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.